Neeraj Sharma

Array ( [id] => 7677192 [patent_doc_number] => 20040152634 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-08-05 [patent_title] => 'Chemokine antagonists and uses thereof' [patent_app_type] => new [patent_app_number] => 10/744876 [patent_app_country] => US [patent_app_date] => 2003-12-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 7081 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 54 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0152/20040152634.pdf [firstpage_image] =>[orig_patent_app_number] => 10744876 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7121984 [patent_doc_number] => 20050013813 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-01-20 [patent_title] => 'Methods of treatment of neurological diseases by interferon antagonists' [patent_app_type] => utility [patent_app_number] => 10/739404 [patent_app_country] => US [patent_app_date] => 2003-12-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 6564 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0013/20050013813.pdf [firstpage_image] =>[orig_patent_app_number] => 10739404 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5649682 [patent_doc_number] => 20060135417 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-06-22 [patent_title] => 'Use of the crh (corticotropin releasing hormone)-ucn (urocortin) system in the treatment of inflammatory diseases' [patent_app_type] => utility [patent_app_number] => 10/535307 [patent_app_country] => US [patent_app_date] => 2003-11-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 8737 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0135/20060135417.pdf [firstpage_image] =>[orig_patent_app_number] => 10535307 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7168796 [patent_doc_number] => 20040077545 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-04-22 [patent_title] => 'Synthetic peptide for neurological disorders' [patent_app_type] => new [patent_app_number] => 10/716981 [patent_app_country] => US [patent_app_date] => 2003-11-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3421 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0077/20040077545.pdf [firstpage_image] =>[orig_patent_app_number] => 10716981 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7311082 [patent_doc_number] => 20040143103 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-22 [patent_title] => 'Vascular endothelial growth factor 2' [patent_app_type] => new [patent_app_number] => 10/696002 [patent_app_country] => US [patent_app_date] => 2003-10-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 47 [patent_figures_cnt] => 47 [patent_no_of_words] => 62288 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0143/20040143103.pdf [firstpage_image] =>[orig_patent_app_number] => 10696002 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7308748 [patent_doc_number] => 20040142388 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-22 [patent_title] => 'Method for detecting chronic dementia diseases, and corresponding VGF peptides and detection reagents' [patent_app_type] => new [patent_app_number] => 10/680087 [patent_app_country] => US [patent_app_date] => 2003-10-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 11698 [patent_no_of_claims] => 57 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 4 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0142/20040142388.pdf [firstpage_image] =>[orig_patent_app_number] => 10680087 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7434127 [patent_doc_number] => 20040266680 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-30 [patent_title] => 'FGF-8 methods of use' [patent_app_type] => new [patent_app_number] => 10/678712 [patent_app_country] => US [patent_app_date] => 2003-10-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 4714 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0266/20040266680.pdf [firstpage_image] =>[orig_patent_app_number] => 10678712 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4833898 [patent_doc_number] => 20080132445 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-06-05 [patent_title] => 'Method for Inducing Mammary Epithelial Cell Differentiation' [patent_app_type] => utility [patent_app_number] => 10/529094 [patent_app_country] => US [patent_app_date] => 2003-09-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 15096 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0132/20080132445.pdf [firstpage_image] =>[orig_patent_app_number] => 10529094 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7325127 [patent_doc_number] => 20040138134 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-15 [patent_title] => 'Method and composition for treatment of skeletal dysplasias' [patent_app_type] => new [patent_app_number] => 10/664605 [patent_app_country] => US [patent_app_date] => 2003-09-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 10999 [patent_no_of_claims] => 66 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0138/20040138134.pdf [firstpage_image] =>[orig_patent_app_number] => 10664605 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7307347 [patent_doc_number] => 20040141946 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-22 [patent_title] => 'Methods of treating neurological conditions with hematopoietic growth factors' [patent_app_type] => new [patent_app_number] => 10/659295 [patent_app_country] => US [patent_app_date] => 2003-09-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 27 [patent_no_of_words] => 28133 [patent_no_of_claims] => 104 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0141/20040141946.pdf [firstpage_image] =>[orig_patent_app_number] => 10659295 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7133453 [patent_doc_number] => 20040043000 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-03-04 [patent_title] => 'Method of modulating fertility in animals' [patent_app_type] => new [patent_app_number] => 10/659200 [patent_app_country] => US [patent_app_date] => 2003-09-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 10704 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0043/20040043000.pdf [firstpage_image] =>[orig_patent_app_number] => 10659200 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7206503 [patent_doc_number] => 20040087503 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-05-06 [patent_title] => 'Modified ciliary neurotrophic factor (cntf ) with reduced immunogenicity' [patent_app_type] => new [patent_app_number] => 10/469837 [patent_app_country] => US [patent_app_date] => 2003-09-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11908 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0087/20040087503.pdf [firstpage_image] =>[orig_patent_app_number] => 10469837 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7250088 [patent_doc_number] => 20050272649 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-12-08 [patent_title] => 'Conjoint administration of morphogens and ACE inhibitors in treatment of chronic renal failure' [patent_app_type] => utility [patent_app_number] => 10/650326 [patent_app_country] => US [patent_app_date] => 2003-08-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 48 [patent_figures_cnt] => 48 [patent_no_of_words] => 49389 [patent_no_of_claims] => 68 [patent_no_of_ind_claims] => 45 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0272/20050272649.pdf [firstpage_image] =>[orig_patent_app_number] => 10650326 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7399450 [patent_doc_number] => 20040039173 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-02-26 [patent_title] => 'Cloning and recombinant production of CRF receptor(s)' [patent_app_type] => new [patent_app_number] => 10/649193 [patent_app_country] => US [patent_app_date] => 2003-08-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 21102 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 51 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0039/20040039173.pdf [firstpage_image] =>[orig_patent_app_number] => 10649193 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6931710 [patent_doc_number] => 20050282745 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-12-22 [patent_title] => 'Non-mammalian GnRH analogs and uses thereof in regulation of fertility and pregnancy' [patent_app_type] => utility [patent_app_number] => 10/639748 [patent_app_country] => US [patent_app_date] => 2003-08-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 40 [patent_figures_cnt] => 40 [patent_no_of_words] => 27283 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0282/20050282745.pdf [firstpage_image] =>[orig_patent_app_number] => 10639748 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7220167 [patent_doc_number] => 20040072220 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-04-15 [patent_title] => 'Neurotonin and use thereof' [patent_app_type] => new [patent_app_number] => 10/467582 [patent_app_country] => US [patent_app_date] => 2003-08-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 14266 [patent_no_of_claims] => 50 [patent_no_of_ind_claims] => 31 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0072/20040072220.pdf [firstpage_image] =>[orig_patent_app_number] => 10467582 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7216730 [patent_doc_number] => 20050260197 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-11-24 [patent_title] => 'Receptor for Oncostatin M' [patent_app_type] => utility [patent_app_number] => 10/636320 [patent_app_country] => US [patent_app_date] => 2003-08-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 15092 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0260/20050260197.pdf [firstpage_image] =>[orig_patent_app_number] => 10636320 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7305870 [patent_doc_number] => 20040116331 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-06-17 [patent_title] => 'Novel role for GLP-1 to mediate responses to disparate stressors' [patent_app_type] => new [patent_app_number] => 10/635230 [patent_app_country] => US [patent_app_date] => 2003-08-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 8065 [patent_no_of_claims] => 50 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0116/20040116331.pdf [firstpage_image] =>[orig_patent_app_number] => 10635230 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5107641 [patent_doc_number] => 20070066519 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-03-22 [patent_title] => 'Use of human growth hormone in multiple system atrophy' [patent_app_type] => utility [patent_app_number] => 10/595076 [patent_app_country] => US [patent_app_date] => 2003-07-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21233 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 20 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0066/20070066519.pdf [firstpage_image] =>[orig_patent_app_number] => 10595076 [rel_patent_id] =>[rel_patent_doc_number] =>)